WEBSITE BSE:0 NSE: Inc. Year: 2006 Industry: Medical Equipment/Supplies/Accessories
Last updated: 00:00
Osel Devices Limited is a leading company specializing in the design and manufacturing of advanced electronic devices and solutions. Established with a vision to innovate, Osel focuses on developing high-quality products for various sectors, including telecommunications, consumer electronics, and industrial applications. The company is known for its commitment to research and development, ensuring that its offerings incorporate the latest technological advancements. Osel Devices is dedicated to sustainability and energy efficiency, integrating...Read More
Osel Devices Limited is a leading company specializing in the design and manufacturing of advanced electronic devices and solutions. Established with a vision to innovate, Osel focuses on developing high-quality products for various sectors, including telecommunications, consumer electronics, and industrial applications. The company is known for its commitment to research and development, ensuring that its offerings incorporate the latest technological advancements. Osel Devices is dedicated to sustainability and energy efficiency, integrating eco-friendly practices in its operations. The company has built a reputation for reliability and excellence, serving clients globally. Its extensive product range includes smart devices, sensors, and connectivity solutions, catering to the evolving needs of its customers. With a strong emphasis on customer satisfaction, Osel Devices Limited continues to expand its market presence while contributing to the growth of the electronics industry. ...Read Less
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Market Cap ₹812 Cr.
Stock P/E 40.5
P/B 8.1
Current Price ₹503.5
Book Value ₹ 61.9
Face Value 10
52W High ₹835
Dividend Yield 0%
52W Low ₹ 186.3
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) |
|---|
| Net Sales |
| Other Income |
| Total Income |
| Total Expenditure |
| Operating Profit |
| Interest |
| Depreciation |
| Exceptional Income / Expenses |
| Profit Before Tax |
| Provision for Tax |
| Profit After Tax |
| Adjustments |
| Profit After Adjustments |
| Adjusted Earnings Per Share |
| #(Fig in Cr.) | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|
| Net Sales | 57 | 65 | 82 | 132 | 186 | |
| Other Income | 0 | 0 | 0 | 0 | 0 | |
| Total Income | 58 | 66 | 82 | 133 | 187 | |
| Total Expenditure | 55 | 61 | 73 | 110 | 153 | |
| Operating Profit | 3 | 5 | 9 | 23 | 34 | |
| Interest | 1 | 1 | 1 | 3 | 3 | |
| Depreciation | 1 | 1 | 1 | 1 | 1 | |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | |
| Profit Before Tax | 2 | 3 | 7 | 19 | 29 | |
| Provision for Tax | 1 | 1 | 2 | 6 | 9 | |
| Profit After Tax | 1 | 2 | 5 | 13 | 20 | |
| Adjustments | 0 | 0 | 0 | 0 | 0 | |
| Profit After Adjustments | 1 | 2 | 5 | 13 | 20 | |
| Adjusted Earnings Per Share | 1.6 | 1.8 | 4 | 11 | 12.4 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 41% | 42% | 0% | 0% |
| Operating Profit CAGR | 48% | 89% | 0% | 0% |
| PAT CAGR | 54% | 115% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 83% | NA% | NA% | NA% |
| ROE Average | 30% | 48% | 41% | 41% |
| ROCE Average | 31% | 40% | 33% | 33% |
| #(Fig in Cr.) | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Shareholder's Funds | 5 | 8 | 12 | 25 | 108 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 3 | 2 | 1 | 8 | 2 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 1 | 1 |
| Total Current Liabilities | 14 | 24 | 35 | 65 | 87 |
| Total Liabilities | 23 | 33 | 49 | 99 | 198 |
| Fixed Assets | 6 | 5 | 7 | 18 | 17 |
| Other Non-Current Assets | 0 | 0 | 0 | 1 | 1 |
| Total Current Assets | 17 | 28 | 43 | 80 | 180 |
| Total Assets | 23 | 33 | 49 | 99 | 198 |
| #(Fig in Cr.) | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 3 | 5 | 5 | 1 | 5 |
| Cash Flow from Operating Activities | -3 | 3 | -11 | 13 | -38 |
| Cash Flow from Investing Activities | 0 | 0 | -2 | -13 | -0 |
| Cash Flow from Financing Activities | 5 | -2 | 8 | 4 | 53 |
| Net Cash Inflow / Outflow | 2 | 1 | -4 | 4 | 14 |
| Closing Cash & Cash Equivalent | 5 | 5 | 1 | 5 | 19 |
| # | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 1.61 | 1.84 | 4.04 | 10.99 | 12.43 |
| CEPS(Rs) | 2.22 | 2.33 | 4.54 | 11.82 | 13.11 |
| DPS(Rs) | 0 | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 5.93 | 6.61 | 10.65 | 21.96 | 66.93 |
| Core EBITDA Margin(%) | 4.85 | 6.7 | 10.55 | 17.01 | 17.92 |
| EBIT Margin(%) | 4.39 | 6.32 | 9.93 | 16.63 | 17.4 |
| Pre Tax Margin(%) | 3.51 | 4.58 | 8.51 | 14.03 | 15.53 |
| PAT Margin (%) | 2.37 | 3.25 | 5.69 | 9.59 | 10.75 |
| Cash Profit Margin (%) | 3.25 | 4.11 | 6.4 | 10.31 | 11.34 |
| ROA(%) | 6.03 | 7.63 | 11.35 | 17.18 | 13.53 |
| ROE(%) | 27.16 | 33.6 | 46.79 | 67.41 | 30.09 |
| ROCE(%) | 16.95 | 26.49 | 35.05 | 54.36 | 31.15 |
| Receivable days | 44.6 | 51.25 | 53.8 | 54.36 | 90.21 |
| Inventory Days | 25.11 | 39.79 | 63.35 | 60.11 | 64.76 |
| Payable days | 36.61 | 63.87 | 82.74 | 94.45 | 85.25 |
| PER(x) | 0 | 0 | 0 | 0 | 19.47 |
| Price/Book(x) | 0 | 0 | 0 | 0 | 3.62 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 0.12 | 0.08 | 0.23 | 0.27 | 2.31 |
| EV/Core EBITDA(x) | 2.2 | 1.11 | 2.14 | 1.55 | 12.86 |
| Net Sales Growth(%) | 0 | 13.58 | 25.51 | 61.48 | 41.01 |
| EBIT Growth(%) | 0 | 63.59 | 97.22 | 170.58 | 47.52 |
| PAT Growth(%) | 0 | 56.1 | 119.49 | 172.19 | 58.09 |
| EPS Growth(%) | 0 | 14.16 | 119.49 | 172.19 | 13.09 |
| Debt/Equity(x) | 1.97 | 1.13 | 1.45 | 1 | 0.46 |
| Current Ratio(x) | 1.18 | 1.17 | 1.2 | 1.23 | 2.05 |
| Quick Ratio(x) | 0.9 | 0.74 | 0.69 | 0.84 | 1.59 |
| Interest Cover(x) | 5.02 | 3.63 | 7.01 | 6.38 | 9.32 |
| Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0.13 |
| # | Sep 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|
| Promoter | 71.53 | 71.53 | 65.21 |
| FII | 4.13 | 1.83 | 0.59 |
| DII | 5.88 | 5.38 | 3.89 |
| Public | 18.46 | 21.26 | 30.32 |
| Others | 0 | 0 | 0 |
| Total | 100 | 100 | 100 |
| # | Sep 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|
| Promoter | 1.15 | 1.15 | 1.15 |
| FII | 0.07 | 0.03 | 0.01 |
| DII | 0.09 | 0.09 | 0.07 |
| Public | 0.3 | 0.34 | 0.54 |
| Others | 0 | 0 | 0 |
| Total | 1.61 | 1.61 | 1.77 |
* The pros and cons are machine generated.
You May Also Know About
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
